Some mammograms are more difficult to read than others. FDA wants breast density data to be included in reports



[ad_1]

The Food and Drug Administration on [March 27] proposed to require mammography providers to indicate to women with dense bad tissue that this condition may make it more difficult to interpret their screening tests and to recommend to their physician that ask their doctor if he should undergo further tests to screen for cancer.

Dense bads have relatively high amounts of glandular tissue and fibrous connective tissue and relatively small amounts of adipose tissue, according to the National Cancer Institute. Nearly half of women aged 40 and over who have mammograms have dense bads. As such a tissue appears in white on a mammogram – just like cancer – it can mask malignant tumors. In addition, dense bads increase the risk of bad cancer in women, says the NCI.

Amy Abernethy, the FDA's Senior Assistant Commissioner, said the proposal would "empower" patients by giving them more information to discuss with their doctor. Breast density information would be included in the summary letter that mammography providers sent to patients, as well as in the full report sent to physicians.

Read the full original message: FDA wants women to get bad density information along with their mammograms

[ad_2]
Source link